Moderna is one of the most mentioned companies in the U.S. across all news items in the past 12 hours, according to Factiva data. Moderna swung to a first-quarter loss of $1.18 billion, or $3.07 a share, from a profit of $79 million, or 19 cents a share, a year earlier. Analysts had forecast a loss of $3.56 a share, on average, according to data provided by FactSet. First-quarter revenue plunged by 91% to $167 million, which still surpassed the average Wall Street target of $93 million. At the peak of the pandemic, in 2022, Moderna generated $19.3 billion in revenue. Dow Jones & Co. owns Factiva.